Harvard Apparatus Regenerative Technology Inc. HRGN
2.30 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
2.30 Day range 2.45
0.96 52-week range 2.46
- YTD
- +25.00%
- 1 year
- +19.17%
- Market cap
- 40.44M
- EPS (ttm)
- -0.40634
- P/E ratio
- -5.66
- YTD return
- +25.00%
- 1-year return
- +19.17%
- Volume
- 700
- Avg volume
- 1.43K
- Open
- 2.30
- Previous close
- 2.30
- Day's range
- 2.30 – 2.45
- 52-week range
- 0.96 – 2.46
1Y +0.37 (+19.17%)
Financials — quick view
HRGN Revenue — quarterly 0
HRGN Net income — quarterly -2.61M
HRGN EPS — quarterly -0.19
News
Harvard Apparatus Regenerative Technology Announces First Patient Treated with Cellspan Esophageal Implant at Mayo Clinic 
Harvard Apparatus Regenerative Technology Collaborates with University of Southern California to Test Treatment for Esophageal Disease 
Critical Comparison: Arch Therapeutics (OTCMKTS:ARTH) vs. Biostage (OTCMKTS:BSTG) 
Harvard Apparatus Regenerative Technology Announces Strategic Collaboration with Children's Hospital Capital institute of Pediatrics in Beijing, China to Advance Treatment for Esophageal Atresia 
Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors 
Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial 
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights 
Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights 
Harvard Apparatus Regenerative Technology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Establish a Research Collaboration to Study the Repair and Regeneration of the Colon following Colectomy 
Harvard Apparatus Regenerative Technology and Renowned Professor/Physician Establish a Collaboration to Repair and Regenerate the Uterus
Your note
Sign in to keep a note on HRGN — it syncs with the Stock Master app.